These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8504557)

  • 1. False-positive serum tricyclic antidepressant screen with cyproheptadine.
    Wians FH; Norton JT; Wirebaugh SR
    Clin Chem; 1993 Jun; 39(6):1355-6. PubMed ID: 8504557
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose.
    Yuan CM; Spandorfer PR; Miller SL; Henretig FM; Shaw LM
    Ther Drug Monit; 2003 Jun; 25(3):299-304. PubMed ID: 12766557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive tricyclic antidepressant drug screen results leading to the diagnosis of carbamazepine intoxication.
    Matos ME; Burns MM; Shannon MW
    Pediatrics; 2000 May; 105(5):E66. PubMed ID: 10799630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine overdose recognized by a tricyclic antidepressant assay.
    Fleischman A; Chiang VW
    Pediatrics; 2001 Jan; 107(1):176-7. PubMed ID: 11134454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of thioridazine on the Automatic Clinical Analyzer serum tricyclic anti-depressant screen.
    Ryder KW; Glick MR
    Am J Clin Pathol; 1986 Aug; 86(2):248-9. PubMed ID: 3739974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive diphenhydramine interference in the EMIT-st assay for tricyclic antidepressants in serum.
    Sorisky A; Watson DC
    Clin Chem; 1986 Apr; 32(4):715. PubMed ID: 3513997
    [No Abstract]   [Full Text] [Related]  

  • 7. Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays.
    Caravati EM; Juenke JM; Crouch BI; Anderson KT
    Ann Pharmacother; 2005 Sep; 39(9):1446-9. PubMed ID: 16046487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2006 Oct; 28(5):662-7. PubMed ID: 17038882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic antidepressants.
    Saidinejad M; Law T; Ewald MB
    Pediatrics; 2007 Sep; 120(3):e504-9. PubMed ID: 17766494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Syva EMIT Toxicological Serum Tricyclic Antidepressant Assay.
    Schroeder TJ; Tasset JJ; Otten EJ; Hedges JR
    J Anal Toxicol; 1986; 10(6):221-4. PubMed ID: 3543495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct detection of therapeutic concentrations of tricyclic antidepressants in whole hemolyzed blood using the EMITtox serum tricyclic antidepressant assay.
    Asselin WM; Leslie JM
    J Anal Toxicol; 1991; 15(4):167-73. PubMed ID: 1943065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2007 Feb; 29(1):134-9. PubMed ID: 17333576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic monitoring of tricyclic antidepressant drugs in plasma or serum by gas chromatography.
    Volin P
    Clin Chem; 1981 Oct; 27(10):1785-7. PubMed ID: 7285340
    [No Abstract]   [Full Text] [Related]  

  • 14. Poor responsivity of qualitative immunoassay for tricyclic antidepressant drugs in serum.
    Osterloh JD
    Clin Chem; 1985 Jan; 31(1):154-5. PubMed ID: 3880677
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine.
    Downs JM; Downs AD; Rosenthal TL; Deal N; Akiskal HS
    J Clin Psychiatry; 1989 Jun; 50(6):226-7. PubMed ID: 2785987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of methodological factors in determining the accuracy and precision of measurements of tricyclic antidepressant drug concentrations in serum.
    Wilson JF; Williams J; Marshall RW; Richens A; Dijkhuis IC; Harteveld AR; de Jong HJ
    Ther Drug Monit; 1986; 8(1):123-5. PubMed ID: 3961890
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of blood collection tubes on tricyclic antidepressant concentration.
    Jewesson PJ; Remick RA
    J Clin Psychopharmacol; 1986 Feb; 6(1):51-2. PubMed ID: 3950068
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced serum tricyclic levels due to gel separators.
    Levy AB; Walters M; Stern SL
    J Clin Psychopharmacol; 1987 Dec; 7(6):423-4. PubMed ID: 3429705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting tricyclic antidepressant measurements in urine in an emergency department setting: comparison of two qualitative point-of-care urine tricyclic antidepressant drug immunoassays with quantitative serum chromatographic analysis.
    Melanson SE; Lewandrowski EL; Griggs DA; Flood JG
    J Anal Toxicol; 2007 Jun; 31(5):270-5. PubMed ID: 17579971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic antidepressant plasma level monitoring: intraindividual variability in everyday practice.
    Vandel S; Bertschy G; Nezeloff S; Bonin B; Volmat R
    Eur J Clin Pharmacol; 1990; 39(6):611-2. PubMed ID: 2095350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.